<PAGE> 1
May 4, 1998
VIA EDGAR AND FACSIMILE
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Mary Brooks Fraser, Esq.
Division of Corporation Finance
Mail Stop 3-9
Ophidian Pharmaceuticals, Inc.
Form 8-A
File No. 001-13835
Gentlemen and Ladies:
Please withdraw our previously filed Form 8-A 12B so that we may file a Form
8-A 12G to register the securities under the Securities Act of 1934.
Very truly yours,
OPHIDIAN PHARMACEUTICALS, INC.
/s/ Douglas C. Stafford
-------------------------------
Douglas C. Stafford, President